{"With": [0], "the": [1, 8, 63, 98, 120, 162, 170, 181, 254, 270, 278, 366, 370, 381, 385, 425, 442, 468, 472, 478, 491, 500, 510, 515, 527, 536, 546, 558, 574, 583, 593, 601, 617, 626, 636, 640, 644, 650, 663, 672, 682, 687, 699, 708, 718, 734, 743, 753, 760, 771, 786, 795, 805, 815, 822], "unprecedented": [2], "morbidity": [3], "and": [4, 45, 165, 169, 173, 177, 273, 277, 281, 285, 314, 373, 376, 388, 409, 416, 429, 433, 460, 481, 504, 513, 518, 540, 561, 587, 604, 630, 653, 676, 685, 690, 712, 747, 763, 774, 799, 810, 836, 839, 842], "mortality": [5], "associated": [6], "with": [7, 73, 79, 153, 236, 265, 294, 406], "COVID-19": [9, 14], "pandemic,": [10], "a": [11, 105, 127, 143, 237, 295], "vaccine": [12, 28, 90, 96], "against": [13, 30], "is": [15, 404, 410, 821], "urgently": [16], "needed.": [17], "We": [18], "investigated": [19], "CoronaVac": [20, 192, 247, 820], "(Sinovac": [21], "Life": [22], "Sciences,": [23], "Beijing,": [24], "China),": [25, 116], "an": [26, 85], "inactivated": [27, 33], "candidate": [29], "COVID-19,": [31], "containing": [32], "severe": [34], "acute": [35], "respiratory": [36], "syndrome": [37], "coronavirus": [38], "2": [39, 122, 211, 256, 444, 642], "(SARS-CoV-2),": [40], "for": [41, 97, 119, 457, 462, 477, 514, 649, 686, 717, 727, 825], "its": [42], "safety,": [43, 808], "tolerability": [44], "immunogenicity.In": [46], "this": [47], "randomised,": [48], "double-blind,": [49], "placebo-controlled,": [50], "phase": [51, 99, 121, 137, 255, 426, 443, 458, 463, 469, 641, 830], "1/2": [52], "clinical": [53], "trial,": [54, 257, 428, 471, 643], "healthy": [55], "adults": [56], "aged": [57], "18-59": [58], "years": [59], "were": [60, 92, 124, 149, 185, 207, 229, 261, 287, 317, 338, 422, 439], "recruited": [61], "from": [62], "community": [64], "in": [65, 142, 334, 369, 384, 391, 424, 441, 490, 499, 509, 526, 535, 545, 567, 573, 582, 592, 611, 616, 625, 635, 662, 671, 681, 698, 707, 733, 742, 752, 780, 785, 794, 804, 828], "Suining": [66], "County": [67], "of": [68, 198, 219, 240, 246, 251, 298, 304, 344, 356, 453, 474, 487, 497, 507, 524, 533, 543, 551, 570, 580, 590, 614, 623, 633, 646, 659, 669, 679, 696, 705, 715, 722, 730, 740, 750, 783, 792, 802, 819], "Jiangsu": [69], "province,": [70], "China.": [71], "Adults": [72], "SARS-CoV-2": [74, 361], "exposure": [75], "or": [76, 84, 248, 310], "infection": [77], "history,": [78], "axillary": [80], "temperature": [81], "above": [82], "37\u00b70\u00b0C,": [83], "allergic": [86], "reaction": [87], "to": [88, 187, 209, 242, 300, 319, 359, 412], "any": [89], "component": [91], "excluded.": [93], "The": [94, 136, 322, 349, 549], "experimental": [95], "1": [100, 138, 189, 427, 459, 470], "trial": [101, 123, 139, 403], "was": [102, 140, 326, 353, 484, 521, 565, 609, 656, 693, 725, 778], "manufactured": [103], "using": [104, 233, 291], "cell": [106], "factory": [107], "process": [108, 129], "(CellSTACK": [109], "Cell": [110], "Culture": [111], "Chamber": [112], "10,": [113], "Corning,": [114], "Wujiang,": [115], "whereas": [117, 596, 766], "those": [118], "produced": [125], "through": [126], "bioreactor": [128], "(ReadyToProcess": [130], "WAVE": [131], "25,": [132, 418], "GE,": [133], "Umea,": [134], "Sweden).": [135], "done": [141], "dose-escalating": [144], "manner.": [145], "At": [146], "screening,": [147, 259], "participants": [148, 184, 228, 260, 286, 336, 392, 421, 438, 447, 489, 572, 661, 732], "initially": [150, 262], "separated": [151, 263], "(1:1),": [152, 264], "no": [154, 266], "specific": [155, 267], "randomisation,": [156, 268], "into": [157, 269, 813], "two": [158, 244, 249, 302, 505, 748], "vaccination": [159, 167, 175, 275, 283, 398, 563, 606], "schedule": [160, 399, 564], "cohorts,": [161], "days": [163, 171, 271, 279, 331, 371, 386, 479, 516, 559, 602, 651, 688, 761, 772], "0": [164, 172, 272, 280, 372, 387, 480, 517, 560, 603, 652, 689, 762, 773], "14": [166, 274, 364, 374, 482, 556, 562, 654, 758, 764], "cohort": [168, 180, 276, 390, 483, 520, 655, 692], "28": [174, 282, 330, 379, 389, 519, 599, 605, 691, 769, 775], "cohort,": [176, 284, 375], "within": [178, 329], "each": [179, 226], "first": [182], "36": [183, 206], "assigned": [186, 208, 231, 289], "block": [188, 210, 234, 238, 292, 296], "(low": [190], "dose": [191, 343, 368, 383, 452, 818, 824], "[3": [193], "\u03bcg": [194, 215, 502, 529, 538, 576, 585, 619, 628, 665, 674, 701, 710, 736, 745, 788, 797, 817], "per": [195, 202, 216, 223], "0\u00b75": [196, 217], "mL": [197, 218], "aluminium": [199, 220], "hydroxide": [200, 221], "diluent": [201, 222], "dose)": [203], "then": [204], "another": [205], "(high-dose": [212], "Coronavc": [213], "[6": [214], "dse]).": [224], "Within": [225], "block,": [227], "randomly": [230, 288], "(2:1),": [232], "randomisation": [235, 293], "size": [239, 297], "six,": [241], "either": [243, 305], "doses": [245, 250, 303], "placebo.": [252, 311], "In": [253, 467, 639], "at": [258, 340, 362, 377, 449, 597, 756, 767], "(2:2:1),": [290], "five,": [299], "receive": [301], "low-dose": [306], "CoronaVac,": [307, 309], "high-dose": [308], "Participants,": [312], "investigators,": [313], "laboratory": [315], "staff": [316], "masked": [318], "treatment": [320], "allocation.": [321], "primary": [323, 350], "safety": [324, 465], "endpoint": [325], "adverse": [327, 475, 647], "reactions": [328, 476, 648], "after": [332, 365, 380, 557, 600, 759, 770], "injection": [333], "all": [335], "who": [337, 393], "given": [339], "least": [341, 450], "one": [342, 451, 631], "study": [345], "drug": [346], "(safety": [347], "population).": [348, 401, 466], "immunogenic": [351], "outcome": [352], "seroconversion": [354, 550, 608, 777], "rates": [355], "neutralising": [357, 552, 723], "antibodies": [358, 553, 724], "live": [360], "day": [363, 378, 555, 598, 757, 768], "last": [367, 382], "completed": [394], "their": [395], "allocated": [396], "two-dose": [397], "(per-protocol": [400], "This": [402], "registered": [405], "ClinicalTrials.gov,": [407], "NCT04352608,": [408], "closed": [411], "accrual.Between": [413], "April": [414, 417], "16": [415], "2020,": [419, 436], "144": [420], "enrolled": [423, 440], "between": [430], "May": [431, 434], "3": [432, 492, 528, 575, 618, 664, 700, 735, 787, 816, 831], "5,": [435], "600": [437], "trial.": [445], "743": [446], "received": [448], "investigational": [454], "product": [455], "(n=143": [456], "n=600": [461], "2;": [464], "incidence": [473, 645], "seven": [485], "(29%)": [486], "24": [488, 498, 508, 525, 534, 571, 581, 591, 615, 624, 634], "ug": [493], "group,": [494, 503, 512, 530, 539, 577, 586, 620, 629, 666, 675, 684, 702, 711, 737, 746, 789, 798], "nine": [495], "(38%)": [496], "6": [501, 537, 584, 627, 673, 709, 744, 796], "(8%)": [506], "placebo": [511, 547, 594, 637, 683, 719, 754, 806], "three": [522, 541], "(13%)": [523, 542], "four": [531], "(17%)": [532], "23": [544, 694, 703], "group.": [548, 638, 720], "on": [554], "seen": [566, 610, 726, 779], "11": [568, 713], "(46%)": [569], "12": [578], "(50%)": [579], "none": [588, 800], "(0%)": [589, 801], "group;": [595], "schedule,": [607, 776], "20": [612], "(83%)": [613], "19": [621], "(79%)": [622], "(4%)": [632], "40": [657], "(33%)": [658], "120": [660, 670, 697, 706], "42": [667], "(35%)": [668], "13": [677], "(22%)": [678], "60": [680, 716, 751], "(19%)": [695, 704], "(18%)": [714], "Seroconversion": [721], "109": [728], "(92%)": [729], "118": [731, 790, 793], "117": [738, 784], "(98%)": [739], "119": [741], "(3%)": [749], "group": [755], "schedule;": [765], "114": [781], "(97%)": [782], "(100%)": [791], "59": [803], "group.Taking": [807], "immunogenicity,": [809], "production": [811], "capacity": [812], "account,": [814], "suggested": [823], "efficacy": [826], "assessment": [827], "future": [829], "trials.Chinese": [832], "National": [833], "Key": [834], "Research": [835], "Development": [837], "Program": [838], "Beijing": [840], "Science": [841], "Technology": [843], "Program.": [844]}